INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS

被引：0
|
作者：
Liu, Chengfei
Zhu, Yezi
Lou, Wei
Cui, Yuanyuan
Evans, Christopher P.
Gao, Allen C.
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.289
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP24-08
引用
收藏
页码：E262 / E262
页数：1
相关论文
共 50 条
  • [21] Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice
    DeMiguel, F
    Lee, SO
    Lou, W
    Xiao, X
    Pflug, BR
    Nelson, JB
    Gao, AC
    PROSTATE, 2002, 52 (02): : 123 - 129
  • [22] STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
    Spiotto, MT
    Chung, TDK
    PROSTATE, 2000, 42 (02): : 88 - 98
  • [23] Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells
    Mora, LB
    Buettner, R
    Seigne, J
    Diaz, J
    Ahmad, N
    Garcia, R
    Bowman, T
    Falcone, R
    Fairclough, R
    Cantor, A
    Muro-Cacho, C
    Livingston, S
    Karras, J
    Pow-Sang, J
    Jove, R
    CANCER RESEARCH, 2002, 62 (22) : 6659 - 6666
  • [24] Constitutively activated STAT3 in myeloma cells.
    Grigorieva, I
    Chapman, M
    Epstein, J
    BLOOD, 1996, 88 (10) : 404 - 404
  • [25] Constitutively active Stat3 triggers the development of autaimmune myocarditis
    Camporeale, Annalisa
    Marino, Francesca
    Brero, Alessia
    Chiarle, Roberto
    Jensen, Ole
    Levi, Renzo
    Poli, Valeria
    CYTOKINE, 2009, 48 (1-2) : 117 - 118
  • [26] Constitutively active STAT3 in T-cells induces a distinct tolerogenic program
    Schmetterer, K. G.
    Neunkirchner, A.
    Haiderer, D.
    Leitner, J.
    Steinberger, P.
    Pickl, W. F.
    IMMUNOLOGY, 2012, 137 : 405 - 406
  • [27] Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines
    Barton, BE
    Karras, JG
    Murphy, TF
    Barton, A
    Huang, HFS
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (01) : 11 - 20
  • [28] Overcoming erlotinib resistance with STAT3 inhibition in pancreatic cancer
    Salzberg, Matthew Philip
    Merchant, Nipun B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [29] RETRACTION: Stat3 Enhances the Growth of LNCaP Human Prostate Cancer Cells in Intact and Castrated Male Nude Mice
    DeMiguel, F.
    Lee, S. O.
    Lou, W.
    Xiao, X.
    Pflug, B. R.
    Nelson, J. B.
    Gao, A. C.
    PROSTATE, 2025,
  • [30] Targeting STAT3 in castration-resistant prostate cancer: Galiellalactone as a direct inhibitor of STAT3 in prostate cancer cells.
    Hellsten, Rebecka
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin Hans
    Kjellstrom, Sven
    Garcia, Victor
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345